z-logo
open-access-imgOpen Access
Abstract 3726: Preclinical activity of PSMA-TTC (BAY 2315497) in combination with androgen receptor antagonists in prostate cancer models
Author(s) -
Stefanie Hammer,
Urs B. Hagemann,
Sabine Zitzmann-Kolbe,
A Dawson Larsen,
Chrstine Ellingsen,
Oliver von Ahsen,
Jenny Karlsson,
Roger M. Bjerke,
Olav B. Ryan,
Pascale Lejeune,
Hartwig Hennekes,
Alan S. Cuthbertson,
Dominik Mumberg
Publication year - 2019
Language(s) - English
Resource type - Conference proceedings
DOI - 10.1158/1538-7445.sabcs18-3726
Subject(s) - enzalutamide , prostate cancer , medicine , lncap , androgen receptor , cancer research , cancer , in vivo , pharmacology , prostate , biology , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here